Tuesday, 22 August 2017

MicroPort Scientific plans portfolio expansion

20 July 2017 | News

The company's short term investment would be in people and education. In long term it is also exploring opportunities to have local manufacturing and partners with the government in 'Make in India' initiatives.

Courtesy- Wikimedia

Courtesy- Wikimedia

MicroPort Scientific India, an Indian arm of Shanghai-based medical device firm MicroPort Scientific Corporation is looking at expanding horizontally and vertically in terms of expansion across the country as well as product portfolios.

The company provides medical solutions covering 10 major disciplines including interventional cardiology, orthopedics, endovascular, neurovascular, electrophysiology, diabetes and endocrine management, surgical management and others. The company has innovative TES (Target Eluting Stent) technology product FireHawk and it is eyeing at about 20 per cent market share in the stent business.

The company's short term investment would be in people and education. In long term it is also exploring opportunities to have local manufacturing and partners with the government in 'Make in India' initiatives.

MicroPort Scientific Corporation is a leading medical device company with business focussing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally and its products currently approved for use in over 5,000 hospitals in 80 countries worldwide.

Under its global expansion programme, Microport has acquired OrthoRecon business of Wright Medical, USA and has made a strategic investment in Lombard Medical of UK.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Are private sector's profits in healthcare soaring in India?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls